KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer

Published:2020-12-25 Issue:9 Volume:15 Page:2412-2422
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Mastoraki Sofia¹^ORCID,Balgkouranidou Ioanna¹,Tsaroucha Emily²,Klinakis Apostolos³^ORCID,Georgoulias Vassilis⁴,Lianidou Evi¹

Affiliation:

1. Analysis of Circulating Tumor Cells Lab of Analytical Chemistry Department of Chemistry University of Athens Greece

2. 8th Department of Pulmonary Diseases ‘Sotiria’ General Hospital for Chest Diseases Athens Greece

3. Biomedical Research Foundation Academy of Athens Greece

4. Department of Medical Oncology IASO General Hospital Athens Greece

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12848

Reference46 articles.

1. Cancer statistics, 2018

2. Multiplatform-based molecular subtypes of non-small-cell lung cancer

3. Exploring the potential of immuno-oncology-based treatment for patients with non-small cell lung cancer

4. Blood-based tumor biomarkers in lung cancer for detection and treatment

5. Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumor cells: from new biological insights to clinical practice;Signal Transduction and Targeted Therapy;2024-09-02

2. Cell-free DNA methylation in the clinical management of lung cancer;Trends in Molecular Medicine;2024-05

3. Exploring the interplay between methylation patterns and non-coding RNAs in non-small cell lung cancer: Implications for pathogenesis and therapeutic targets;Heliyon;2024-01

4. Recent advances of nucleic acid-based cancer biomarkers and biosensors;Coordination Chemistry Reviews;2023-12

5. Liquid biopsy for early detection of lung cancer;Chinese Medical Journal Pulmonary and Critical Care Medicine;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3